Pharmaceutical News

RSS

HHS Secretary to visit Bradenton Healthcare Center to discuss the importance of H1N1 vaccinations

Health and Human Services Secretary Kathleen Sebelius will visit the East Manatee Family Healthcare Center in Bradenton, Fla. on Tuesday, November 10.

10 Nov 2009

Despite economic slowdown, Central and Eastern European countries still represent an attractive healthcare market

Despite the global economic decline, Central and Eastern European (CEE) countries such as Poland, the Czech Republic, Slovakia, Hungary, Bulgaria and Romania still represent an attractive healthcare market.

10 Nov 2009

NIH awards $6.8 million subcontract to Kineta to develop vaccine immune boosters

Kineta, Inc. announced today it has been awarded a $6.8 million subcontract from the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), to develop novel vaccine adjuvants (agents that help boost the immune system). The Kineta subcontract is part of a larger $13 million award to the University of Washington.

10 Nov 2009

Teva Pharmaceutical Industries amends patent infringement lawsuit against Momenta Pharmaceuticals/Sandoz

Teva Pharmaceutical Industries Ltd. announced today it is seeking to amend its existing complaint against Momenta Pharmaceuticals, Inc./Sandoz Inc. to include patent infringement of three additional patents related to the characterization of COPAXONE® (glatiramer acetate injection). The proposed updated complaint has been filed under seal with the U.S. District Court for the Southern District of New York along with a motion requesting that the Court grant Teva leave to amend.

10 Nov 2009

Cannabinoid medicine: Challenges for health care providers and its potential benefits for patients

Groundbreaking articles in current issues of Journal of Opioid Management, for the first time explore, in depth, the emergence of cannabinoid medicine, its challenges for health care providers and its potential benefits for patients.

10 Nov 2009

H1N1 vaccine updates from Pennsylvania Department of Health

The federal Centers for Disease Control and Prevention, or CDC, has allocated a total of 1,351,400 doses of H1N1 vaccine to Pennsylvania to date, the state Department of Health announced today.

10 Nov 2009

Astellas receives exclusive rights to develop and commercialize linaclotide compound in Asia

Ironwood Pharmaceuticals, Inc. and Astellas Pharma Inc. today announced that they have entered into an agreement providing Astellas exclusive rights to develop and commercialize the investigational compound linaclotide in Japan, Indonesia, Korea, the Philippines, Taiwan, and Thailand.

10 Nov 2009

Novartis to acquire 85% stake in Zhejiang Tianyuan Bio-Pharmaceutical for US$125 million

Hard To Treat Diseases (HTDS.PK) www.htdsmedical.com, announced today that Novartis, a US$41 billion international healthcare company, is acquiring an 85% stake in HTDS' H1N1 Vaccine partner, Zhejiang Tianyuan Bio-Pharmaceutical Co., Ltd., for US$125 million.

10 Nov 2009

MicroDose Therapeutx acquires potential compounds for treatment of respiratory syncytial virus

MicroDose Therapeutx Inc. (formerly MicroDose Technologies) today announced that it has acquired a portfolio of compounds for the potential treatment of respiratory syncytial virus (RSV) from ViroPharma Incorporated (Exton, PA). The lead investigational compound in the portfolio is an inhalable small molecule fusion inhibitor, now called MDT-637.

10 Nov 2009

Global Health Initiative launched by The Association of University Technology Managers

The Association of University Technology Managers (AUTM) announced the launch of a new Global Health Initiative that promotes licensing practices that support access to essential medicines by developing countries.

10 Nov 2009

Flu-Ease provides flu shots at airports

First there was a shot and a beer, then the "shot heard around the world," and now it’s a shot on the fly. The most useful airport amenity available to air travelers this season may turn out to be flu shots.

10 Nov 2009

FDA approves Istodax for treatment of Cutaneous T-cell Lymphoma

The U.S. Food and Drug Administration has approved Istodax (romidepsin), an injectable medication, for treatment of patients with a rare form of cancer known as Cutaneous T-cell Lymphoma (CTCL).

10 Nov 2009

European Union funds a three-year project to establish a research network for complementary medicine study

A three-year project called CAMbrella will receive nearly 1.5 million euros of European Union funding to establish a research network for the study of complementary medicine. The Center for Naturopathic Research at "Rechts der Isar," the university hospital of the Technische Universitaet Muenchen will coordinate the project for the winning applicant group, which includes 16 scientific organizations from 12 European countries.

10 Nov 2009

FDA accepts ChemGenex Pharmaceuticals' NDA for Omapro

ChemGenex Pharmaceuticals Limited announced today that the U.S. Food & Drug Administration (FDA) has accepted the company’s New Drug Application (NDA) for Omapro™ (omacetaxine mepesuccinate) for the treatment of patients with chronic myeloid leukemia (CML) who have failed treatment with imatinib and who have developed the Bcr-Abl T315I mutation.

10 Nov 2009

Diabetic Care Services responds to NRF's updated “Buyer Beware” list

Diabetic Care Services responds to the National Retail Federation’s updated “Buyer Beware” list with tips on avoiding fraudulent diabetes supplies. The NRF updated its list of common household items, including diabetes supplies, sold on online auction sites that are at risk of being stolen or tainted.

10 Nov 2009

TRICARE South Region beneficiaries urged to get H1N1 influenza vaccinations

Humana Military Healthcare Services, a wholly-owned subsidiary of Humana Inc. (NYSE: HUM), encourages TRICARE South Region beneficiaries to get their H1N1 influenza vaccinations in an effort to reduce the spread of the virus. Anticipating a greater need for the shots, the Department of Defense (DoD) is encouraging all military personnel to obtain the vaccines.

9 Nov 2009

VaxInnate licensed to use 3M Drug Delivery Systems' TLR agonists

3M Drug Delivery Systems has signed an agreement with VaxInnate Corporation under which VaxInnate acquires the use of 3M’s patented toll-like receptor (TLR) agonists for use as vaccine adjuvants. Data suggest that 3M’s TLR agonists could enhance vaccine potency, potentially enabling VaxInnate to develop vaccines that provide faster, more robust protection.

9 Nov 2009

Scientific article supports AEterna Zentaris' development of perifosine inhibitor

AEterna Zentaris Inc., a global biopharmaceutical company focused on endocrine therapy and oncology, today announced publication of a scientific article in the renowned Journal of Urology, supporting the development of the Company's PI3K/Akt pathway inhibitor oral compound, perifosine, for the treatment of cancer.

9 Nov 2009

Shire's INTUNIV for treating ADHD now available in the U.S.

Shire plc, the global specialty biopharmaceutical company, today announced the availability of INTUNIV(TM) (guanfacine) Extended Release Tablets in pharmacies across the United States for the treatment of Attention-Deficit/Hyperactivity Disorder (ADHD) in children and adolescents ages 6 to 17.

9 Nov 2009

Covidien contraindicates use of its Optimark gadoversetamide injection

Covidien, a leading global provider of healthcare products, today announced that it will voluntarily contraindicate the use of its Optimark™ gadoversetamide injection, a gadolinium-based contrast agent (GBCA), in magnetic resonance imaging (MRI) procedures involving patients with severe renal impairment.

9 Nov 2009

Pharmaceutical News

HHS Secretary to visit Bradenton Healthcare Center to discuss the importance of H1N1 vaccinations

Despite economic slowdown, Central and Eastern European countries still represent an attractive healthcare market

NIH awards $6.8 million subcontract to Kineta to develop vaccine immune boosters

Teva Pharmaceutical Industries amends patent infringement lawsuit against Momenta Pharmaceuticals/Sandoz

Cannabinoid medicine: Challenges for health care providers and its potential benefits for patients

H1N1 vaccine updates from Pennsylvania Department of Health

Astellas receives exclusive rights to develop and commercialize linaclotide compound in Asia

Novartis to acquire 85% stake in Zhejiang Tianyuan Bio-Pharmaceutical for US$125 million

MicroDose Therapeutx acquires potential compounds for treatment of respiratory syncytial virus

Global Health Initiative launched by The Association of University Technology Managers

Flu-Ease provides flu shots at airports

FDA approves Istodax for treatment of Cutaneous T-cell Lymphoma

European Union funds a three-year project to establish a research network for complementary medicine study

FDA accepts ChemGenex Pharmaceuticals' NDA for Omapro

Diabetic Care Services responds to NRF's updated “Buyer Beware” list

TRICARE South Region beneficiaries urged to get H1N1 influenza vaccinations

VaxInnate licensed to use 3M Drug Delivery Systems' TLR agonists

Scientific article supports AEterna Zentaris' development of perifosine inhibitor

Shire's INTUNIV for treating ADHD now available in the U.S.

Covidien contraindicates use of its Optimark gadoversetamide injection

Redefining control and consistency in anaerobic microbiome workflows

AI in Healthcare: How generative tools are transforming clinical practice

The future of automation: Machine learning–driven hepatocyte and organoid counting

Latest News